Search research articles
Contact Us
Filters
Showing results (631-640 of 762) with videos related to
Page
of 77
Sort By:
Cancers
|
December 1, 2020
Targeting the RhoGEF βPIX/COOL-1 in Glioblastoma: Proof of Concept Studies
Kate Connor, David W Murray, Monika A Jarzabek, et al.
Breast (Edinburgh, Scotland)
|
June 25, 2021
Clinicopathological response to neoadjuvant therapies and pathological complete response as a biomarker of survival in human epidermal growth factor receptor-2 enriched breast cancer - A retrospective cohort study
Matthew G Davey, Eoin Kerin, C O'Flaherty, et al.
The Journal of Urology
|
February 15, 2015
Incidence and Predictors of Upgrading and Up Staging among 10,000 Contemporary Patients with Low Risk Prostate Cancer
Kathryn T Dinh, Brandon A Mahal, David R Ziehr, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 17, 2025
A roadmap for future clinical research in advanced prostate cancer: Findings from the Advanced Prostate Cancer Consensus Conference (APCCC) 2024
Ursula M Vogl, Sara Merler, Antonio Angrisani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 4, 2023
MyPathway Human Epidermal Growth Factor Receptor 2 Basket Study: Pertuzumab + Trastuzumab Treatment of a Tissue-Agnostic Cohort of Patients With Human Epidermal Growth Factor Receptor 2-Altered Advanced Solid Tumors
Christopher J Sweeney, John D Hainsworth, Ron Bose, et al.
Clinical Genitourinary Cancer
|
January 19, 2016
Duration of Androgen Deprivation Therapy for High-Risk Prostate Cancer: Application of Randomized Trial Data in a Tertiary Referral Cancer Center
Vinayak Muralidhar, Meredith M Regan, Lillian Werner, et al.
Scientific Reports
|
February 1, 2024
A clinically relevant computed tomography (CT) radiomics strategy for intracranial rodent brain tumour monitoring
Kate Connor, Emer Conroy, Kieron White, et al.
Nutrients
|
October 14, 2023
Vitamins and Minerals for Blood Pressure Reduction in the General, Normotensive Population: A Systematic Review and Meta-Analysis of Six Supplements
Benjamin J Behers, Julian Melchor, Brett M Behers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 15, 2021
Transcriptional profiling of primary prostate tumor in metastatic hormone-sensitive prostate cancer and association with clinical outcomes: correlative analysis of the E3805 CHAARTED trial
A A Hamid, H-C Huang, V Wang, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
May 1, 1997
Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal models
T J Carty, F J Sweeney, R J Griffiths, et al.
Page
of 77
Search research articles
Search
Showing results (631-640 of 762) with videos related to
Sort By:
Page
of 77
Cancers
|
December 1, 2020
Targeting the RhoGEF βPIX/COOL-1 in Glioblastoma: Proof of Concept Studies
Kate Connor, David W Murray, Monika A Jarzabek, et al.
Breast (Edinburgh, Scotland)
|
June 25, 2021
Clinicopathological response to neoadjuvant therapies and pathological complete response as a biomarker of survival in human epidermal growth factor receptor-2 enriched breast cancer - A retrospective cohort study
Matthew G Davey, Eoin Kerin, C O'Flaherty, et al.
The Journal of Urology
|
February 15, 2015
Incidence and Predictors of Upgrading and Up Staging among 10,000 Contemporary Patients with Low Risk Prostate Cancer
Kathryn T Dinh, Brandon A Mahal, David R Ziehr, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 17, 2025
A roadmap for future clinical research in advanced prostate cancer: Findings from the Advanced Prostate Cancer Consensus Conference (APCCC) 2024
Ursula M Vogl, Sara Merler, Antonio Angrisani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 4, 2023
MyPathway Human Epidermal Growth Factor Receptor 2 Basket Study: Pertuzumab + Trastuzumab Treatment of a Tissue-Agnostic Cohort of Patients With Human Epidermal Growth Factor Receptor 2-Altered Advanced Solid Tumors
Christopher J Sweeney, John D Hainsworth, Ron Bose, et al.
Clinical Genitourinary Cancer
|
January 19, 2016
Duration of Androgen Deprivation Therapy for High-Risk Prostate Cancer: Application of Randomized Trial Data in a Tertiary Referral Cancer Center
Vinayak Muralidhar, Meredith M Regan, Lillian Werner, et al.
Scientific Reports
|
February 1, 2024
A clinically relevant computed tomography (CT) radiomics strategy for intracranial rodent brain tumour monitoring
Kate Connor, Emer Conroy, Kieron White, et al.
Nutrients
|
October 14, 2023
Vitamins and Minerals for Blood Pressure Reduction in the General, Normotensive Population: A Systematic Review and Meta-Analysis of Six Supplements
Benjamin J Behers, Julian Melchor, Brett M Behers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 15, 2021
Transcriptional profiling of primary prostate tumor in metastatic hormone-sensitive prostate cancer and association with clinical outcomes: correlative analysis of the E3805 CHAARTED trial
A A Hamid, H-C Huang, V Wang, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
May 1, 1997
Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal models
T J Carty, F J Sweeney, R J Griffiths, et al.
Page
of 77